Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 585

1.

MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer.

Callegari E, Domenicali M, Shankaraiah RC, D'Abundo L, Guerriero P, Giannone F, Baldassarre M, Bassi C, Elamin BK, Zagatti B, Ferracin M, Fornari F, Altavilla G, Blandamura S, Silini EM, Gramantieri L, Sabbioni S, Negrini M.

Mol Ther Nucleic Acids. 2018 Dec 6;14:239-250. doi: 10.1016/j.omtn.2018.11.018. [Epub ahead of print]

PMID:
30641476
2.

Management of Pancreatic Cystic Lesions.

Perri G, Marchegiani G, Frigerio I, Dervenis CG, Conlon KC, Bassi C, Salvia R.

Dig Surg. 2019 Jan 11:1-9. doi: 10.1159/000496509. [Epub ahead of print] Review.

3.

Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis.

Klompmaker S, Peters NA, van Hilst J, Bassi C, Boggi U, Busch OR, Niesen W, Van Gulik TM, Javed AA, Kleeff J, Kawai M, Lesurtel M, Lombardo C, Moser AJ, Okada KI, Popescu I, Prasad R, Salvia R, Sauvanet A, Sturesson C, Weiss MJ, Zeh HJ, Zureikat AH, Yamaue H, Wolfgang CL, Hogg ME, Besselink MG; E-AHPBA DP-CAR study group.

Ann Surg Oncol. 2019 Jan 4. doi: 10.1245/s10434-018-07101-0. [Epub ahead of print]

PMID:
30610560
4.

Ablation treatments in unresectable pancreatic cancer.

Paiella S, De Pastena M, Romeo F, D'onofrio M, Fontana M, Pea A, De Marchi G, Crinò SF, Bassi C, Salvia R.

Minerva Chir. 2019 Jan 2. doi: 10.23736/S0026-4733.18.07881-1. [Epub ahead of print]

PMID:
30600963
5.

Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort.

Uzunoglu FG, Welte MN, Gavazzi F, Maggino L, Perinel J, Salvia R, Janot M, Reeh M, Perez D, Montorsi M, Zerbi A, Adham M, Uhl W, Bassi C, Izbicki JR, Malleo G, Bockhorn M.

Eur J Surg Oncol. 2018 Dec 19. pii: S0748-7983(18)32034-1. doi: 10.1016/j.ejso.2018.12.012. [Epub ahead of print]

PMID:
30585172
6.

The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis.

Marchegiani G, Andrianello S, Miatello C, Pollini T, Secchettin E, Tedesco G, D'Onofrio M, Malleo G, Bassi C, Salvia R.

Dig Surg. 2018 Dec 12:1-8. doi: 10.1159/000495039. [Epub ahead of print]

PMID:
30541002
7.

Results of First-round of Surveillance in Individuals at High-risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.

Paiella S, Capurso G, Cavestro GM, Butturini G, Pezzilli R, Salvia R, Signoretti M, Crippa S, Carrara S, Frigerio I, Bassi C, Falconi M, Iannicelli E, Giardino A, Mannucci A, Laghi A, Laghi L, Frulloni L, Zerbi A; Italian Association for the Study of the Pancreas (AISP).

Am J Gastroenterol. 2018 Dec 11. doi: 10.1038/s41395-018-0414-z. [Epub ahead of print]

PMID:
30538291
8.

Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases.

Paiella S, De Pastena M, Faustini F, Landoni L, Pollini T, Bonamini D, Giuliani T, Bassi C, Esposito A, Tuveri M, Salvia R.

Eur J Surg Oncol. 2018 Nov 29. pii: S0748-7983(18)32019-5. doi: 10.1016/j.ejso.2018.11.021. [Epub ahead of print]

PMID:
30527222
9.

Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation.

Paiella S, De Pastena M, D'Onofrio M, Crinò SF, Pan TL, De Robertis R, Elio G, Martone E, Bassi C, Salvia R.

Transl Gastroenterol Hepatol. 2018 Oct 26;3:80. doi: 10.21037/tgh.2018.10.05. eCollection 2018. Review.

10.

Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where?

Marchegiani G, Landoni L, Andrianello S, Masini G, Cingarlini S, D'Onofrio M, De Robertis R, Davì M, Capelli P, Manfrin E, Amodio A, Paiella S, Malleo G, Damoli I, Miotto M, Bianchi B, Nessi C, Vivani E, Scarpa A, Salvia R, Bassi C.

Neuroendocrinology. 2018 Nov 27. doi: 10.1159/000495774. [Epub ahead of print]

PMID:
30481765
11.

Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary.

Luchini C, Pea A, Yu J, He J, Salvia R, Riva G, Weiss MJ, Bassi C, Cameron JL, Hruban RH, Goggins M, Wolfgang CL, Scarpa A, Wood LD, Lawlor RT.

Mod Pathol. 2018 Nov 22. doi: 10.1038/s41379-018-0183-7. [Epub ahead of print]

PMID:
30467323
12.

Current Definition of and Controversial Issues Regarding Postoperative Pancreatic Fistulas.

Marchegiani G, Andrianello S, Salvia R, Bassi C.

Gut Liver. 2018 Nov 13. doi: 10.5009/gnl18229. [Epub ahead of print] Review.

13.

Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy.

Seykora TF, Maggino L, Malleo G, Lee MK 4th, Roses R, Salvia R, Bassi C, Vollmer CM Jr.

J Gastrointest Surg. 2019 Jan;23(1):135-144. doi: 10.1007/s11605-018-3959-7. Epub 2018 Nov 7.

PMID:
30406578
14.

Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data.

Marchegiani G, Andrianello S, Dal Borgo C, Secchettin E, Melisi D, Malleo G, Bassi C, Salvia R.

HPB (Oxford). 2018 Oct 23. pii: S1365-182X(18)34463-0. doi: 10.1016/j.hpb.2018.09.013. [Epub ahead of print]

PMID:
30366881
15.

Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases.

Pea A, Yu J, Marchionni L, Noe M, Luchini C, Pulvirenti A, de Wilde RF, Brosens LA, Rezaee N, Javed A, Gobbo S, Regi P, Salvia R, Bassi C, He J, Weiss MJ, Cameron JL, Offerhaus GJA, Hruban RH, Lawlor RT, Scarpa A, Heaphy CM, Wood LD, Wolfgang CL.

Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003022. [Epub ahead of print]

PMID:
30339629
16.

Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis.

Malleo G, Maggino L, Ferrone CR, Marchegiani G, Warshaw AL, Lillemoe KD, Bassi C, Castillo CF, Salvia R.

Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003083. [Epub ahead of print]

PMID:
30339622
17.

T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.

Bresin A, Ragone G, Cristofoletti C, Arcelli D, Bassi C, Caprini E, Fiorenza MT, Helmer Citterich M, Russo G, Narducci MG.

PLoS One. 2018 Oct 4;13(10):e0204775. doi: 10.1371/journal.pone.0204775. eCollection 2018.

18.

International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.

van Roessel S, Kasumova GG, Verheij J, Najarian RM, Maggino L, de Pastena M, Malleo G, Marchegiani G, Salvia R, Ng SC, de Geus SW, Lof S, Giovinazzo F, van Dam JL, Kent TS, Busch OR, van Eijck CH, Koerkamp BG, Abu Hilal M, Bassi C, Tseng JF, Besselink MG.

JAMA Surg. 2018 Dec 1;153(12):e183617. doi: 10.1001/jamasurg.2018.3617. Epub 2018 Dec 19.

PMID:
30285076
19.

Importance of main pancreatic duct dilatation in IPMN undergoing surveillance.

Marchegiani G, Andrianello S, Morbin G, Secchettin E, D'Onofrio M, De Robertis R, Malleo G, Bassi C, Salvia R.

Br J Surg. 2018 Dec;105(13):1825-1834. doi: 10.1002/bjs.10948. Epub 2018 Aug 14.

PMID:
30106195
20.

Clinical Implications of Intraoperative Fluid Therapy in Pancreatic Surgery.

Andrianello S, Marchegiani G, Bannone E, Masini G, Malleo G, Montemezzi GL, Polati E, Bassi C, Salvia R.

J Gastrointest Surg. 2018 Dec;22(12):2072-2079. doi: 10.1007/s11605-018-3887-6. Epub 2018 Jul 31.

PMID:
30066067

Supplemental Content

Loading ...
Support Center